z.moreau
Submits third-party assay reports on material purchased directly. Based in Coimbra.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
99.16%
n=8
Suppliers covered
8
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043139 | BPC-157 | SSA | SSA-2601-N6863 | Janoshik | 2026-Q2 | 97.78 | 4.67 | 99.8 | Buyer-sourced | 1 | FAIL |
| AX-2026-042328 | Gonadorelin | TFC | TFC-2511-E2186 | Janoshik | 2026-Q2 | 99.65 | 2.29 | 98.4 | Laboratory-retained | 0 | PASS |
| AX-2026-041807 | Exenatide | ASY | ASY-{CAT}-2827 | Janoshik | 2026-Q2 | 99.27 | 4.13 | 98.6 | Buyer-sourced | 0 | PASS |
| AX-2026-043564 | Liraglutide | SIG | SIG-2508-6459 | PeptideMeter | 2026-Q1 | 97.90 | 5.48 | 95.6 | Buyer-sourced | 0 | PASS |
| AX-2026-042978 | Semaglutide | MKM | MKM-2508-R3717 | Kestrel | 2026-Q1 | 99.89 | 5.05 | 101.6 | Buyer-sourced | 0 | PASS |
| AX-2025-020632 | Semaglutide | GL Biochem | GLBI-2502-B7974 | Kestrel | 2025-Q3 | 98.82 | 5.46 | 92.1 | Supplier-supplied | 1 | FAIL |
| AX-2025-019440 | MOTS-c | JEEP | JEEP-2507-W7622 | Janoshik | 2025-Q3 | 99.65 | 4.61 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-018412 | Semaglutide | WWB | WWB-2502-W1846 | Medutest | 2025-Q1 | 99.05 | 5.91 | 101.7 | Buyer-sourced | 1 | MARGINAL |